Emergent Biosolutions (EBS) Misses Q3 EPS by 4c, Reaffirms
EBS Hot Sheet
EPS Growth %: +96.9%Financial Fact:
Provision for (benefit from) income taxes: -3.64M
Today's EPS Names:
TARO, BRLI, TLB, More
Emergent Biosolutions Inc (NYSE: EBS) reports Q3 EPS of $0.03, 4 cents below the analyst estimate of $0.07. Revenue for the quarter was $43.3 million, which compares to the estimate of $49.56 million.
Reaffirms FY09 sales
Reaffirms FY09 sales
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Rue21, Inc. (RUE) Tops Q1 EPS by 3c; Boosts FY12 EPS Outlook; Approves $50M Buyback
- ATA, Inc. (ATAI) Misses Q4 EPS by 1c; Guides FY13 Revs Below
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
